• Requests must come from an Accredited Provider or Medical Education Company if requesting support for CME.
  • Format must be predominantly digital in nature, given the uncertainties regarding the global pandemic.
  • Audience: Hepatologists and other liver specialists, gastroenterologists and advanced practice providers working in hepatology or gastroenterology practice settings and metabolic disease specialists (e.g., endocrinologists, diabetologists, cardiometabolic specialists)
  • Must be Moore’s learning level 4 or higher.
  • Must include enduring materials.
  • Medical Educational Objectives
    • Nonalcoholic Steatohepatitis (NASH): disease education, guidance and guideline updates, identification and diagnosis of patients and management of NASH.
    • Can be focused on public health and policy, research and/or clinical practice.

Corporate Headquarters

Madrigal is a clinical-stage biopharmaceutical company developing a potential first-to-market novel therapy for patients with non-alcoholic steatohepatitis (NASH) and liver fibrosis.